CN114073644A - 含有胶囊的化妆料组合物 - Google Patents
含有胶囊的化妆料组合物 Download PDFInfo
- Publication number
- CN114073644A CN114073644A CN202110806340.3A CN202110806340A CN114073644A CN 114073644 A CN114073644 A CN 114073644A CN 202110806340 A CN202110806340 A CN 202110806340A CN 114073644 A CN114073644 A CN 114073644A
- Authority
- CN
- China
- Prior art keywords
- capsule
- cosmetic composition
- composition according
- stabilizer
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 112
- 239000000203 mixture Substances 0.000 title claims abstract description 77
- 239000002537 cosmetic Substances 0.000 title claims abstract description 60
- 239000000126 substance Substances 0.000 claims abstract description 10
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 239000012071 phase Substances 0.000 claims description 27
- 239000003381 stabilizer Substances 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 229920006318 anionic polymer Polymers 0.000 claims description 17
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 17
- 229920006317 cationic polymer Polymers 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000008346 aqueous phase Substances 0.000 claims description 11
- 230000005484 gravity Effects 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- -1 polydimethylsiloxane Polymers 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 229920006037 cross link polymer Polymers 0.000 claims description 8
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- 239000000049 pigment Substances 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- 150000005846 sugar alcohols Polymers 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 5
- 229920005862 polyol Polymers 0.000 claims description 5
- 150000003077 polyols Chemical class 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 4
- 229920002125 Sokalan® Polymers 0.000 claims description 4
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 3
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 3
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 3
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 229920003169 water-soluble polymer Polymers 0.000 claims 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims 1
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims 1
- 229960005323 phenoxyethanol Drugs 0.000 claims 1
- 239000003086 colorant Substances 0.000 abstract description 6
- 239000002552 dosage form Substances 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 238000007599 discharging Methods 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 22
- 239000004615 ingredient Substances 0.000 description 20
- 230000008859 change Effects 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 229940048053 acrylate Drugs 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 3
- 229910000271 hectorite Inorganic materials 0.000 description 3
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 229960000281 trometamol Drugs 0.000 description 3
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 2
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- KGKQNDQDVZQTAG-UHFFFAOYSA-N 8-methylnonyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)(C)C KGKQNDQDVZQTAG-UHFFFAOYSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 229940051182 aluminum dimyristate Drugs 0.000 description 2
- YNQRLDQNSBVJGU-UHFFFAOYSA-K aluminum;tetradecanoate;hydroxide Chemical compound [OH-].[Al+3].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O YNQRLDQNSBVJGU-UHFFFAOYSA-K 0.000 description 2
- 229920001586 anionic polysaccharide Polymers 0.000 description 2
- 150000004836 anionic polysaccharides Chemical class 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- OQBIVESRYIWBPL-UHFFFAOYSA-N decan-4-yl octanoate Chemical compound CCCCCCCC(=O)OC(CCC)CCCCCC OQBIVESRYIWBPL-UHFFFAOYSA-N 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical group CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- FBCQUCJYYPMKRO-UHFFFAOYSA-N prop-2-enyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC=C FBCQUCJYYPMKRO-UHFFFAOYSA-N 0.000 description 2
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 2
- 229940047670 sodium acrylate Drugs 0.000 description 2
- 229940104256 sodium taurate Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940104261 taurate Drugs 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079784 disodium stearoyl glutamate Drugs 0.000 description 1
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229940102552 disteardimonium hectorite Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- MSRJTTSHWYDFIU-UHFFFAOYSA-N octyltriethoxysilane Chemical compound CCCCCCCC[Si](OCC)(OCC)OCC MSRJTTSHWYDFIU-UHFFFAOYSA-N 0.000 description 1
- 229960003493 octyltriethoxysilane Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
- A61K8/898—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/08—Preparations containing skin colorants, e.g. pigments for cheeks, e.g. rouge
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/654—The particulate/core comprising macromolecular material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
本发明涉及一种稳定地含有胶囊的化妆料组合物。作为本发明的一个方面的化妆料组合物具有优异的担载有着色剂等的有效成分的胶囊的物理和化学稳定性。因此,上述化妆料组合物即使在长期保管时也不会存在因胶囊内的成分与胶囊外的成分之间的接触和反应而引起的剂型不稳定的问题。另外,上述化妆料组合物通过使用化妆料时产生的摩擦力排出捕集在胶囊中的着色剂等,可以获得戏剧性的妆容效果。
Description
技术领域
本发明涉及一种稳定地含有胶囊的化妆料组合物。
背景技术
在化妆品领域,胶囊主要用于防止特定成分的变败。通常在化妆品领域,已开发出不与化妆料和组合物一起加工而单独加工胶囊本身后将其与化妆料组合物混合而制成的化妆品,但现有方法存在制造繁琐、制造费用高的问题,并且存在将化妆料涂抹于皮肤后胶囊的残留物会残留在皮肤上而令使用者感到不快的问题。对此,曾开发出无需单独的胶囊制造工艺而利用皮肤膜的双层结构在化妆料中自动形成胶囊的技术,但发现了如下问题:胶囊在化妆料中容易分解,或者所形成的胶囊中所含的化妆料组合物的量少,并且胶囊之间的个体差异大。
因此,需要开发一种含有胶囊的形状或尺寸即使在长期保管化妆品时也能保持恒定的稳定胶囊的化妆料组合物。
现有技术文献
专利文献
(专利文献0001)KR 10-1994-0025557 A
发明内容
要解决的课题
在一个方面,本发明的目的是提供一种稳定地含有胶囊的化妆料组合物。
在一个方面,本发明的目的是提供一种含有能够稳定地担载有效成分的胶囊的化妆料组合物。
在一个方面,本发明的目的是提供一种含有直至因使用者使用化妆料而引起的外力起作用前保持物理和化学稳定性的胶囊的化妆料组合物。
在一个方面,本发明的目的是提供一种包含通过组合物中成分之间的反应而自胶囊化的胶囊的化妆料组合物。
在一个方面,本发明的目的是提供一种含有分散性优异的胶囊的化妆料组合物。
课题的解决手段
为了实现上述目的,本发明在一个方面提供了一种含有胶囊的化妆料组合物,其包含担载有效成分的胶囊;以及胶囊稳定剂,其中,上述胶囊包括包含阴离子聚合物和阳离子聚合物的壳(shell),并且上述胶囊稳定剂包括含苯基的醇。
发明效果
作为本发明的一个方面的化妆料组合物具有优异的担载有诸如着色剂等有效成分的胶囊的物理、化学和电稳定性。因此,上述化妆料组合物即使在长期保管时也不会存在因胶囊内的成分与胶囊外的成分之间的接触和反应而引起的胶囊破坏等的剂型不稳定问题。另外,上述化妆料组合物借助于使用化妆料时产生的摩擦力来排出捕集在胶囊中的着色剂等,可以获得戏剧性的妆容效果。
具体实施方式
以下,将详细描述本发明。
在下文中,将更详细地描述各构成,但这仅仅是一个示例,并且本发明的权利范围不限于以下内容。
本发明在一个方面是一种含有胶囊的化妆料组合物,上述化妆料组合物包含担载有效成分的胶囊;以及胶囊稳定剂,其中,上述胶囊包括包含阴离子聚合物和阳离子聚合物的壳(shell),并且上述胶囊稳定剂包括含苯基的醇。
在一个方面,上述“胶囊”可以是指具有能够分离内部和外部环境的膜或壳结构从而在内部能够含有特定成分的捕集体。
在一个方面,上述胶囊中可以担载有有效成分。“有效成分”可以是指直接或间接参与获得化妆料组合物所需的效果的物质。例如,上述有效成分可以包括皮肤状态改善用物质,例如用于改善诸如痤疮等特定疾病或皮肤状态的提取物等自然衍生物质、人工合成物质等,并且可以包括用于赋予外显美容效果的物质,例如着色剂、颜料等的色素。
在一个方面,本发明的胶囊可以以通过化妆料组合物中成分之间的作用将特定成分捕集在内部的形式自形成,而无需单独的胶囊制造工艺。
在一个方面,除了含苯基的醇之外,上述胶囊稳定剂还可以包括多元醇(polyhydric alcohol)。
上述组合物通过包含含苯基的醇或含苯基的醇和多元醇,可以确保包括包含阴离子聚合物和阳离子聚合物的壳的胶囊的剂型内稳定性。例如,本发明的胶囊可以使因胶囊壳与化妆料组合物中的胶囊外部环境中存在的成分之间的电和化学相互作用而引起的胶囊壳的破坏现象最小化。因此,通过控制捕集在胶囊中的成分与胶囊外部环境中存在的成分之间的接触,可以有效地控制因成分之间的反应而引起的沉着等的剂型稳定性下降问题。
在一个方面,基于组合物的总重量,上述胶囊稳定剂的含量可以为0.3~8重量%。
在上述方面,基于组合物的总重量,上述胶囊稳定剂的含量可以为0.3~8重量%,或0.35~7重量%,或0.4~6.5重量%或0.45~6重量%。当胶囊稳定剂的含量满足上述范围时,可以期待优异的胶囊稳定度,当超出上述范围时,可能发生胶囊形成力降低或所形成的胶囊容易破坏的问题。
在一个方面,当上述组合物包含含苯基的醇作为胶囊稳定剂时,胶囊形成后,所形成的胶囊的稳定度可得到提高。
具体地,上述胶囊稳定剂中含苯基的醇,在没有其他胶囊稳定剂的情况下单独包含时,基于组合物的总重量,含量可以为0.3~0.8重量%。
作为胶囊稳定剂,可以包括含苯基的醇和多元醇,当同时包含含苯基的醇和多元醇时,基于组合物的总重量,含苯基的醇的含量可以为0.3~0.8重量%,多元醇的含量可以为0.01~7.7重量%。
在上述方面,多元醇可以包括选自由乙基己基甘油、1,2-己二醇、丁二醇(butylene glycol)、丙二醇(propanediol)和二丙二醇组成的组中的一种以上。在这种情况下,基于组合物的总重量,乙基己基甘油、1,2-己二醇、丙二醇、丁二醇、二丙二醇的含量分别可以为0.01~0.1重量%、0.01~2重量%、0.01~3重量%、0.01~5重量%、0.01~3重量%。
在一个方面,上述组合物还可以包含适量的分散剂、螯合剂、pH调节剂、溶剂、增稠剂、色素、成膜剂、粘合剂、保湿剂/皮肤调理剂和功能性化妆品主要成分这样的功能性成分等。
在一个方面,上述螯合剂可以包括EDTA二钠、EDTA三钠或EDTA四钠,上述pH调节剂可以包括氨丁三醇、三乙醇胺或咪唑烷基脲等。
另外,上述功能性成分可以包括诸如甘油等保湿剂、美白改善、皱纹改善、紫外线阻断等的功能性化妆品成分和诸如锂蒙脱石(hectorite)类、聚氨酯-79等油增稠剂或诸如辛基十二醇等皮肤调理剂。
另外,上述成膜剂可以包括甲基丙烯酸甲酯交联聚合物、二氧化硅或甲基丙烯酸烯丙酯交联聚合物。
另外,上述增稠剂可以包括油增稠剂,例如,可以包括诸如锂蒙脱石类、聚氨酯-79、糊精棕榈酸酯等油增稠剂。
另外,上述pH调节剂可以包括氨丁三醇、三乙醇胺或咪唑烷基脲。
另外,溶剂可以包括有机溶剂,例如可以包括氢化聚(C6-14烯烃)、二苯基聚二甲基硅氧烷、异壬酸异壬酯、二辛基醚、碳酸亚丙酯、碳酸二辛酯、新戊酸异癸酯或辛酸丙基庚酯。
在一个方面,上述组合物可以包括包含阴离子聚合物、胶囊稳定剂和水的水相部;包含阳离子聚合物的油相部;以及包含色素的粉末部。
在一个方面,上述油相部和水相部的比重可以依次为1:0.5~1.5。上述比重可以包括在1气压、25℃下测量的比重。具体地,上述组合物中油相部和水相部的比重可以为1:0.75~1.25,或1:0.85~1.20。当组合物中包含的油相部和水相部的比重与上述相同时,可以使组合物中形成的胶囊的分散稳定度极大化。
基于组合物的总重量,上述组合物中油相部的含量可以为1~95重量%,优选为10~70重量%,更优选为15~50重量%。
另外,基于组合物的总重量,上述组合物中水相部的含量可以为10~90重量%,优选为20~85重量%,更优选为60~80重量%。
在一个具体例中,上述化妆料组合物的胶囊可以自形成,具体地,通过上述水相部、油相部和粉末部的混合,可以自形成粉末部中的着色剂等捕集在内部的状态的胶囊。此时,基于组合物的总重量,上述水相部、油相部和粉末部的含量可以分别依次为55~83重量%、15~30重量%和2~15重量%。
在一个方面,除了阴离子聚合物、胶囊稳定剂和水之外,上述水相部还可以包括诸如EDTA二钠、EDTA三钠、EDTA四钠等螯合剂、诸如甘油等保湿剂、诸如氨丁三醇、三乙醇胺、咪唑烷基脲等pH调节剂、美白改善、皱纹改善、紫外线阻断等的功能性主要成分等。
另外,除了阳离子聚合物之外,上述油相部还可以包括诸如氢化聚(C6-14烯烃)、二苯基聚二甲基硅氧烷、异壬酸异壬酯、二辛基醚、碳酸亚丙酯、碳酸二辛酯、新戊酸异癸酯或辛酸丙基庚酯等有机溶剂、诸如锂蒙脱石类(例如二硬脂二甲铵锂蒙脱石(disteardimonium hectorite))、聚氨酯-79、糊精棕榈酸酯等油增稠剂、诸如辛基十二醇等皮肤调理剂。
另外,上述粉末部可以包括诸如二氧化钛、氧化铁类等色素,除此之外,还可以包括诸如甲基丙烯酸甲酯交联聚合物、二氧化硅或甲基丙烯酸烯丙酯交联聚合物等成膜剂、诸如三乙氧基辛基硅烷或二甲基甲硅烷基化硅石等粘合剂、诸如硬脂酰谷氨酸二钠等表面活性剂、诸如氢氧化铝或二肉豆蔻酸铝(aluminum dimyristate)等涂布剂。
另外,当阳离子聚合物为100重量份时,上述阴离子聚合物的含量可以为10~150重量份,或优选为15~120重量份,或优选为20~100重量份,或优选为30~90重量份,或更优选为40~80重量份。
在一个方面,当上述组合物中所含的阴离子聚合物的含量超出上述范围时,可能发生变色、粘度变化等的剂型稳定性问题,并且可能发生胶囊被破坏等降低胶囊的稳定性的问题。
上述组合物在一个方面可以是水包油型或油包水型组合物。
在一个方面,上述组合物的胶囊的直径可以为0.01~5000微米,或0.1~3000微米,或1~2000微米,或50~1000微米。当胶囊的直径超出上述范围时,可能发生胶囊容易被破坏或者有效成分担载量过少的问题。
另外,上述阴离子聚合物可以包括选自由卡波姆、卡波姆钠、丙烯酸钠交联聚合物-2(sodium acrylates crosspolymer-2)、丙烯酸羟乙酯和丙烯酰二甲基牛磺酸钠共聚物组成的组中的一种以上和选自由丙烯酰二甲基牛磺酸铵/VP共聚物、聚丙烯酰二甲基牛磺酸钠、丙烯酰二甲基牛磺酸铵/山嵛醇聚醚-25甲基丙烯酸酯交联聚合物和丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物(acrylates/C10-30 alkyl acrylate crosspolymer)、阴离子多糖(anionic polysaccharide)组成的组中的一种以上。
优选地,作为阴离子聚合物,可以包括卡波姆和丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物的组合。
另外,上述阳离子聚合物可以包括氨丙基聚二甲基硅氧烷或氨端聚二甲基硅氧烷中的一种以上,优选地可以包括氨端聚二甲基硅氧烷。
另外,上述化妆料组合物的粘度可以为3,000~20,000cps,或5,000~18,000,或6,000~15,000cps。
另外,上述化妆料的剂型可以包括凝胶型。
在一个方面,上述化妆料组合物可以包括粉底、提亮化妆品、紫外线阻断剂、精华、妆前乳、遮瑕膏等。
以下,将通过制备例和实施例更详细地描述本发明。这些制备例和实施例仅用于示例本发明,对于本领域的普通技术人员来说显而易见的是,本发明的范围不应被解释为限于这些实施例。
[制备例]粉底的制备
利用下表1中记载的成分来制备粉底。具体地,将下表1的1号至5号的成分中除3号成分外的其余成分混合来制备水相部,然后计量3号成分并将其与4%的水混合,投入上述水相部中并混合。另外,将6号至8号的成分单独混合来制备油相部。另外,将9号至12号的成分混合及均质化的粉末部添加到油相部中并混合。最后,在用AGI均质混合器搅拌上述水相部的同时,添加上述粉末部和油相部的混合物来制备化妆料组合物。
[表1]
[实验例1]胶囊稳定剂和含量导致的胶囊形成和稳定度评价
如下表2所示,通过改变成分的含量来制备高附着胶囊粉底,并确认是否生成胶囊以及胶囊是否稳定。
对于胶囊稳定度评价,测量和肉眼观察了5摄氏度(℃)、室温、40摄氏度、50摄氏度、循环的腔室中的根据时间经过的胶囊形状和尺寸等。
对于与表1相比省略的成分,以与表1相同的条件使用。所制备的实施例1至4和比较例1至7的油相:水相的比重比例相同地为1:0.88。
[表2]
[表3]
其结果,作为胶囊稳定剂,当胶囊稳定剂的总含量为0.3~8.0重量%,含苯基的醇类的含量为0.3~0.8重量%时,可以在化妆料中稳定地形成胶囊。
对于除了含苯基的醇类之外还包含脱氢乙酸/苯甲醇或苯甲酸钠作为胶囊稳定剂的情况,当包含含苯基的醇类但超出上述含量范围时,可以确认所形成的胶囊的稳定度大幅降低。
[实验例2]油相:水相比重比例导致的胶囊的分散度评价
除了将分散在油相中的粉末相含量调节在5重量%的范围内并且油相:水相的比重比例如下变更之外,用与实施例3相同的组成制备实施例5至10,然后对化妆料中的胶囊的分散度进行评价。
对于分散度评价,确认了5摄氏度、室温、40摄氏度、50摄氏度、循环的腔室中的化妆料中的胶囊分散稳定度。
[表4]
○:所有形成的胶囊均稳定且均匀分散
△:一部分胶囊偏向上侧或下侧分散
×:所有形成的胶囊均偏向上侧或下侧分散
其结果,当油相:水相比重的比例在1:0.5~1.5范围内时,大体上表现出优异的分散性,当超出上述范围时,确认了分散度不好,例如胶囊偏向化妆料的上侧或下侧分散等。
另外,特别是当油相:水相的比例在1:0.85~1.2内时,显示出所有胶囊均稳定且均匀分布从而形成良好美感的结果。
[实验例3]阴离子聚合物:阳离子聚合物的比例导致的长期剂型变化
除了阴离子聚合物和阳离子聚合物的重量如下变更之外,用与实施例3相同的组成制备实施例11至15,并确认阴离子聚合物:阳离子聚合物的比例导致的化妆料组合物的长期剂型变化。
对于长期剂型变化评价,通过肉眼等测量了5摄氏度、室温、40摄氏度、50摄氏度、循环的腔室中的根据时间经过的产品的pH变化、变色、粘度变化和胶囊的沉淀等。
[表5]
[表6]
实施例11 | 实施例12 | 实施例13 | 实施例14 | 实施例15 | |
长期剂型变化(肉眼) | × | ○ | ○ | △ | × |
○:经过6个月后也没有变化
△:经过3个月后一部分变性
×:1个月以内大部分变性
其结果,基于100重量份的阳离子聚合物,当阴离子聚合物在40~80重量份以内时,可以确认长期剂型稳定度最优异。
Claims (10)
1.一种含有胶囊的化妆料组合物,
上述化妆料组合物包含:
担载有效成分的胶囊;和
胶囊稳定剂,
上述胶囊包括包含阴离子聚合物和阳离子聚合物的壳,
上述胶囊稳定剂包括含苯基的醇。
2.如权利要求1所述的含有胶囊的化妆料组合物,其中,
上述胶囊稳定剂还包括多元醇。
3.如权利要求1所述的含有胶囊的化妆料组合物,其中,
基于组合物的总重量,上述胶囊稳定剂的含量为0.3~8.0重量%。
4.如权利要求1所述的含有胶囊的化妆料组合物,其中,
上述有效成分包括色素和皮肤状态改善用物质中的一种以上。
5.如权利要求1所述的含有胶囊的化妆料组合物,其中,
上述组合物包含:
包含阴离子聚合物、胶囊稳定剂和水的水相部;
包含阳离子聚合物的油相部;和
包含色素的粉末部。
6.如权利要求5所述的含有胶囊的化妆料组合物,其中,
上述油相部和水相部的比重依次为1:0.5~1.5。
7.如权利要求1所述的含有胶囊的化妆料组合物,其中,
当阳离子聚合物为100重量份时,上述阴离子聚合物的含量为10~150重量份。
8.如权利要求1所述的含有胶囊的化妆料组合物,其中,
上述阴离子聚合物包括卡波姆和丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物中的一种以上,
上述阳离子聚合物包括氨端聚二甲基硅氧烷或氨丙基聚二甲基硅氧烷,
上述含苯基的醇包括苯氧乙醇或羟基苯乙酮。
9.如权利要求2所述的含有胶囊的化妆料组合物,其中,
上述多元醇包括选自由乙基己基甘油、1,2-己二醇、丁二醇、丙二醇和二丙二醇组成的组中的一种以上。
10.如权利要求1所述的含有胶囊的化妆料组合物,其中,
在上述组合物中,
作为胶囊稳定剂,包括含苯基的醇和多元醇,
基于组合物的总重量,上述含苯基的醇的含量为0.3~0.8重量%,
基于组合物的总重量,多元醇的含量为0.01~7.7重量%。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200101918A KR102220752B1 (ko) | 2020-08-13 | 2020-08-13 | 캡슐을 함유하는 화장료 조성물 |
KR10-2020-0101918 | 2020-08-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114073644A true CN114073644A (zh) | 2022-02-22 |
CN114073644B CN114073644B (zh) | 2024-04-19 |
Family
ID=75169292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110806340.3A Active CN114073644B (zh) | 2020-08-13 | 2021-07-16 | 含有胶囊的化妆料组合物 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20220047473A1 (zh) |
KR (1) | KR102220752B1 (zh) |
CN (1) | CN114073644B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102369109B1 (ko) * | 2021-09-08 | 2022-03-02 | 한국콜마주식회사 | 캡슐을 함유하는 자외선 차단용 화장료 조성물 |
KR102407550B1 (ko) * | 2021-11-09 | 2022-06-13 | 한국콜마주식회사 | 화장용 캡슐 조성물 및 이를 포함하는 화장료 조성물 |
KR102365650B1 (ko) * | 2021-11-22 | 2022-02-23 | 한국콜마주식회사 | 셀프 캡슐레이션 제형의 화장료 조성물 및 이를 포함하는 시트 마스크 |
FR3129287A1 (fr) * | 2021-11-24 | 2023-05-26 | Capsum | Dispersion macroscopique avec phase grasse dispersee à teneur élevée en polymere cationique et en pigments |
KR102559129B1 (ko) * | 2023-03-15 | 2023-07-25 | 한국콜마주식회사 | 캡슐 또는 비드를 포함하는 화장료 조성물 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150272861A1 (en) * | 2014-03-28 | 2015-10-01 | Nusil Technology Llc | Dispersions containing encapsulated materials and compositions using same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140043397A (ko) * | 2011-06-29 | 2014-04-09 | 솔-겔 테크놀로지스 리미티드 | 코어-셸 마이크로캡슐을 함유하는 안정화된 국소 제제 |
KR102078712B1 (ko) * | 2016-06-30 | 2020-02-19 | (주)아모레퍼시픽 | 안정도가 개선된 다중 유화 조성물 |
KR102160146B1 (ko) * | 2018-12-28 | 2020-09-28 | 주식회사 케이피티 | 오일분산형 이중캡슐의 제조방법 및 이에 의해 제조된 오일분산형 이중캡슐 |
-
2020
- 2020-08-13 KR KR1020200101918A patent/KR102220752B1/ko active IP Right Grant
-
2021
- 2021-07-16 CN CN202110806340.3A patent/CN114073644B/zh active Active
- 2021-08-03 US US17/392,659 patent/US20220047473A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150272861A1 (en) * | 2014-03-28 | 2015-10-01 | Nusil Technology Llc | Dispersions containing encapsulated materials and compositions using same |
Also Published As
Publication number | Publication date |
---|---|
KR102220752B1 (ko) | 2021-03-02 |
US20220047473A1 (en) | 2022-02-17 |
CN114073644B (zh) | 2024-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114073644A (zh) | 含有胶囊的化妆料组合物 | |
JP6734786B2 (ja) | 高い湿潤点を有する粒子を含むマイクロカプセルを含む組成物 | |
CN108024941B (zh) | 水包油型乳化化妆料 | |
JP4567585B2 (ja) | 化粧料 | |
WO2001051558A1 (fr) | Microgels et preparations d'application externe contenant ces microgels | |
EP1847262A1 (en) | Cosmetic | |
EP2823804B1 (en) | Color changing composition comprising pigments and a high amount of water | |
US20150105476A1 (en) | O/w type cosmetic composition with improved dosage form stability | |
KR102196342B1 (ko) | 신규 분말 중합체, 그의 제조 방법, 및 증점제로서의 용도 | |
KR20170085954A (ko) | 수중유형 유화 화장료 | |
WO2001013884A2 (de) | Kosmetische und/oder pharmazeutische zubereitungen enthaltend polysiloxanhaltige polymerisate und deren verwendung | |
CN113747876A (zh) | 含有多孔金属氧化物球体的化妆品或个人护理配制剂 | |
AU2013280910A1 (en) | Sunscreen compositions containing an ultraviolet radiation-absorbing polyester | |
CN110662528B (zh) | 油包水型化妆材料 | |
KR101358920B1 (ko) | 폴리머와 계면활성제의 상호작용으로 캡슐을 안정적으로함입한 화장료 조성물 | |
EP3636249A1 (en) | Cosmetic | |
CN116135199A (zh) | 具有可见油粒子的水包油型化妆品组合物 | |
KR102226108B1 (ko) | 유화 친수성 겔화제를 포함하는 유액 형태의 색상 변화 조성물 | |
KR102574547B1 (ko) | 무기분체를 안정적으로 내포하는 워터 드롭 매크로 에멀젼 화장료 조성물 및 이의 제조방법 | |
JP5693862B2 (ja) | 美白日焼け止め化粧料 | |
KR102575094B1 (ko) | 고함량의 오일을 포함하는 저점도의 수중유형 화장료 조성물 | |
KR20180106778A (ko) | 고함량 오일을 안정화시킨 반투명 수중유형(o/w) 화장료 조성물 및 이의 제조방법 | |
WO2020175789A1 (ko) | 세륨옥사이드를 포함하는 광차단용 화장료 조성물 | |
KR101338503B1 (ko) | 비중조절제를 포함하는 화장료 조성물 | |
JP2022063984A (ja) | 水中油型乳化固形化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |